PCV45 COST-EFFECTIVENESS OF CYP2C9 AND VKORC1 GENOTYPE-GUIDED WARFARIN ANTICOAGULATION CARE- THE IMPLEMENTATION OF DISCRETE EVENT SIMULATION MODEL ON THE NATURAL HISTORY OF VENOUS THROMBOEMBOLISM
May 1, 2011, 00:00
10.1016/j.jval.2011.02.232
https://www.valueinhealthjournal.com/article/S1098-3015(11)00371-8/fulltext
Title :
PCV45 COST-EFFECTIVENESS OF CYP2C9 AND VKORC1 GENOTYPE-GUIDED WARFARIN ANTICOAGULATION CARE- THE IMPLEMENTATION OF DISCRETE EVENT SIMULATION MODEL ON THE NATURAL HISTORY OF VENOUS THROMBOEMBOLISM
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00371-8&doi=10.1016/j.jval.2011.02.232
First page :
A40
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
783